WCN26-6639 Case Report of Telitacicept Treatment in Chronic Kidney Disease Without Renal Biopsy

Read full text Summarise with VIRAT
Authors: Ming Pei, Bing Liu, Yiwen Peng, Meijuan Zhang, Keqi Huang, Jinghua Feng, Wenxuan Ren
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Due to social, religious, and physical constraints, numerous chronic kidney disease (CKD) patients cannot undergo renal biopsy, creating an urgent clinical need. This study aims to preliminarily explore the therapeutic potential of the novel biologic agent telitacicept for CKD patients who refuse or are unable to undergo renal biopsy, focusing on its efficacy and safety.

Fields of Study & Subjects

Chronic Kidney Disease and Diabetes Renal Diseases and Glomerulopathies Dialysis and Renal Disease Management

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
104508–104508
Publication date
25 March 2026
Language
EN